Silver Book Fact

Impact of a healthy lifestyle on age-related macular degeneration (AMD)

A study exploring the impact of a healthy lifestyle on age-related macular degeneration (AMD) found that women whose diets were the healthiest (scored on the 2005 Healthy Eating Index) had 46% lower odds of developing early AMD than those whose diets were the least healthy.  It also found that women with the most physical activity had 54% lower odds for early AMD compared to those with the least amount of physical activity.

Mares J, Voland R, Sondel S, Millen A, et al. Healthy Lifestyles Related to Subsequent Prevalence of Age-Related Macular Degeneration. Arch Ophthalmol. 2011; 129(4): 322-326. http://archopht.jamanetwork.com/article.aspx?articleid=427181

Reference

Title
Healthy Lifestyles Related to Subsequent Prevalence of Age-Related Macular Degeneration
Publication
Arch Ophthalmol
Publication Date
2011
Authors
Mares J, Voland R, Sondel S, Millen A, et al.
Volume & Issue
Volume 129, Issue 4
Pages
322-326
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Macugen to treat wet age-related macular degeneration (AMD)
    A new FDA-approved ophthalmic drug that treats wet age-related macular degeneration (AMD)– pegaptanib sodium (Macugen)– reduced vision loss in 70% of clinical trial patients.  
  • Multifoca electroretinogram (mFERG) measures show abnormal function of the retina early in–and even prior to–diabetic retinopathy onset and could enhance monitoring of the early stages of disease progression in individuals.  
  • Remote Interpretation of Retinal Imaging for DR
    Use of remote interpretation of retinal imaging in diabetics sent via tele-ophthalmology, improved the frequency of screening from 32% to 71% in only 12 months.  
  • The ACCORD Eye Study found that combination lipid therapy with a fibrate and statin (compared with statin treatment alone) reduced progression of diabetic retinopathy in type 2 diabetics by around…  
  • Studies of patients with myocardial infarction found that warfarin reduced stroke risk compared to placeboby 40% to 55%.